November 20 is a date that will live in infamy for investors who were short a tiny pharmaceutical company named KaloBios Pharmaceuticals. And it started with a tweet.

Martin Shkreli, the Founder and Chief Executive Officer of Turing Pharmaceuticals AG, has acquired 70% of its outstanding shares $KBIO
— Martin Shkreli (@MartinShkreli) November 20, 2015

from Forbes – Tech http://ift.tt/1MZ4P4L
via IFTTT